Cargando…
A cutting-edge immunomodulatory interlinkage between HOTAIR and MALAT1 in tumor-associated macrophages in breast cancer: A personalized immunotherapeutic approach
Breast cancer (BC) is one of the most common cancers, accounting for 2.3 million cases worldwide. BC can be molecularly subclassified into luminal A, luminal B HER2-, luminal B HER2+, HER2+, and triple-negative breast cancer (TNBC). These molecular subtypes differ in their prognosis and treatment st...
Autores principales: | Amer, Hoda T., Eissa, Reda A., El Tayebi, Hend M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649622/ https://www.ncbi.nlm.nih.gov/pubmed/36387279 http://dx.doi.org/10.3389/fmolb.2022.1032517 |
Ejemplares similares
-
Mechanistic studies of MALAT1 in respiratory diseases
por: Wu, Wenzheng, et al.
Publicado: (2022) -
Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021) -
Possible Immunotherapeutic Strategies Based on Carcinogen-Dependent Subgroup Classification for Oral Cancer
por: Sun, Jiwei, et al.
Publicado: (2021) -
Metabolism-Related Signature Analysis Uncovers the Prognostic and Immunotherapeutic Characteristics of Renal Cell Carcinoma
por: Zhang, Jianye, et al.
Publicado: (2022) -
Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis
por: Zhao, Zhixun, et al.
Publicado: (2022)